Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 170 of 170 entries
View as:

A Study in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01245569 Org: User:
Start: 04/30/11 End: 03/31/12 Due: 03/31/13

A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)

Phase: N/A Priority: Normal
NCT ID: NCT03086460 Org: User:
Start: 09/08/17 End: 07/28/18 Due: 07/28/19

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

Phase: N/A Priority: Normal
NCT ID: NCT04636814 Org: User:
Start: 07/12/21 End: 04/10/27 Due: 04/10/28

BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)

Phase: N/A Priority: Normal
NCT ID: NCT00929851 Org: User:
Start: 10/31/09 End: 07/31/12 Due: 07/31/13

CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT04077671 Org: User:
Start: 10/17/18 End: 01/07/21 Due: 01/07/22

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03197818 Org: User:
Start: 12/14/16 End: 05/26/20 Due: 05/26/21

Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality

Phase: N/A Priority: Normal
NCT ID: NCT03594175 Org: User:
Start: 02/12/20 End: 07/10/23 Due: 07/10/24

Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT05710692 Org: User:
Start: 08/01/23 End: 03/31/28 Due: 03/31/29

A Study to Compare the Effects of Two Propellants in Adults With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05472662 Org: User:
Start: 08/03/22 End: 10/31/22 Due: 10/31/23

A Study in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01570478 Org: User:
Start: 07/31/12 End: 02/28/14 Due: 02/28/15

Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)

Phase: N/A Priority: Normal
NCT ID: NCT01102543 Org: User:
Start: 03/31/10 End: 03/31/11 Due: 03/31/12

Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01344655 Org: User:
Start: 04/30/11 End: 09/30/12 Due: 09/30/13

Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02743013 Org: User:
Start: 04/30/16 End: 07/31/16 Due: 07/31/17

Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT02970630 Org: User:
Start: 01/31/17 End: 02/22/18 Due: 02/22/19

Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

Phase: N/A Priority: Normal
NCT ID: NCT06941025 Org: User:
Start: 06/30/25 End: 12/31/34 Due: 12/31/35

Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00497523 Org: User:
Start: 03/31/06 End: 01/31/07 Due: 01/31/08

Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)

Phase: N/A Priority: Normal
NCT ID: NCT04502433 Org: User:
Start: 01/06/21 End: 03/17/22 Due: 03/17/23

A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)

Phase: N/A Priority: Normal
NCT ID: NCT03235986 Org: User:
Start: 08/28/17 End: 05/05/20 Due: 05/05/21

Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT03453112 Org: User:
Start: 10/09/17 End: 12/28/21 Due: 12/28/22

Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast)

Phase: N/A Priority: Normal
NCT ID: NCT04739774 Org: User:
Start: 02/22/21 End: 04/26/21 Due: 04/26/22